Immunome, Inc.
Immunome, Inc.（IMNM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
imnm · 股价预测 · 13 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 13 位华尔街分析师
Buy
13 位分析师
共识
评级分布
12 个月目标价
High
$40.00
Consensus
$36.33
+95.8% upside
Low
$32.00
Median: $36.5 · Last Close: $18.56
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$36.33
95.8% upside
High Target
$40
115.6%
Low Target
$32
72.5%
Current Price
$18.56
as of today
Based on analyst price targets, the IMNM stock price prediction for the next 12 months ranges from $32 to $40. The consensus IMNM price forecast of $36.33 implies 95.8% upside from the current price of $18.56.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $17.63 | ↓ 5.00% |
1-day model range: $17.51–$17.75. Peak: $17.75 (-5.00%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $19 | +3.9% |
| 2028 | $20 | +6.1% |
| 2029 | $20 | +7.4% |
| 2030 | $20 | +8.1% |
| 2031 | — | +8.5% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · IMNM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-28 | Truist Securities | Maintains | Buy→Buy |
| 2026-05-15 | Leerink Partners | Maintains | Outperform→Outperform |
| 2026-05-13 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-03-04 | Stephens & Co. | Maintains | Overweight→Overweight |
| 2026-03-04 | Craig-Hallum | Maintains | Buy→Buy |
| 2026-01-15 | Wedbush | Maintains | Outperform→Outperform |
| 2025-12-16 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-12-16 | Lake Street | Maintains | Buy→Buy |
| 2025-12-16 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-17 | Stephens & Co. | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Immunome, Inc. (IMNM) stock. Of the recent 25 rating actions, 0 were upgrades and 0 were downgrades. 13 analysts currently cover IMNM.
分析师推荐趋势
IMNM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$3M
↓ 98.9% YoY
Revenue Next Year
$62M
↑ 2355.8% YoY
EPS This Year
$-2.14
EPS Next Year
$-2.14
↓ 0.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast IMNM EPS of $-2.14 for the current fiscal year, based on estimates from 10 analysts. The IMNM revenue forecast is $3M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
IMNM 股价预测由两类独立数据源支撑：来自 13 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。IMNM 的共识目标价为 $36.33（+95.8% 上行空间），分析师共识为 Buy。
IMNM 的短期预测（明日）为 $17.63（-5.00%）。 IMNM 对 2027 年的股价预测均值为 $19。 IMNM 对 2030 年的预测区间为 $19–$22。
Immunome, Inc. 在 NASDAQ 上市，代码 IMNM。IMNM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
IMNM 预测 · 8 个问题根据 13 位华尔街分析师，IMNM 的 12 个月平均目标价为 $36.33，最高 $40.00、最低 $32.00。若有图表，中位目标价可在上方查看。相对当前价 $18.56，隐含约 +95.8% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.